Cargando…
Maintenance treatment with esomeprazole following initial relief of non-steroidal anti-inflammatory drug-associated upper gastrointestinal symptoms: the NASA2 and SPACE2 studies
Non-steroidal anti-inflammatory drugs (NSAIDs), including selective cyclo-oxygenase-2 (COX-2) inhibitors, cause upper gastrointestinal (GI) symptoms that are relieved by treatment with esomeprazole. We assessed esomeprazole for maintaining long-term relief of such symptoms. Six hundred and ten patie...
Autores principales: | Hawkey, Christopher J, Talley, Nicholas J, Scheiman, James M, Jones, Roger H, Långström, Göran, Næsdal, Jorgen, Yeomans, Neville D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1866019/ https://www.ncbi.nlm.nih.gov/pubmed/17391505 http://dx.doi.org/10.1186/ar2124 |
Ejemplares similares
-
Is ranitidine therapy sufficient for healing peptic ulcers associated with non-steroidal anti-inflammatory drug use?
por: YEOMANS, N D, et al.
Publicado: (2006) -
Study on the preventive effect of intravenous esomeprazole in the management of nonvarices upper gastrointestinal bleeding
por: Sun, Xing-cheng, et al.
Publicado: (2021) -
Short-Term Symptomatic Relief in Gastroesophageal Reflux Disease: A Comparative Study of Esomeprazole and Vonoprazan
por: Sakurai, Kouichi, et al.
Publicado: (2018) -
Conference on NASA Centers for Commercial Development of Space - NASA CCDS
por: El-Genk, M S, et al.
Publicado: (1995) -
NASA's scientist-astronauts
por: David, Shayler, et al.
Publicado: (2007)